TAMPA, Fla. - A Florida federal jury on April 9 found that Novartis Pharmaceuticals Corp. did not negligently fail to warn a plaintiff's doctor about the risks of osteonecrosis of the jaw (ONJ) from the company's bisphosphonate drugs Aredia and Zometa (Ruth Dopson-Troutt, et al. v. Novartis Pharmaceuticals Corporation, No. 8:06-1708, M.D. Fla., Tampa Div.).